ID
39147
Descripción
Study ID: 108062 Clinical Study ID: 108062 Study Title: A three part, staggered cohort, open-label and double blind, randomized, placebo controlled study to investigate the efficacy, safety, tolerability and pharmacokinetics of eltrombopag, a thrombopoietin receptor agonist, in previously treated pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag PETIT: Eltrombopag in PEdiatric patients with Thrombocytopenia from ITP Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00908037 https://clinicaltrials.gov/ct2/show/NCT00908037 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: eltrombopag, Placebo Trade Name: N/A Study Indication: Purpura, Thrombocytopaenic, Idiopathic The study consists of a screening, Day 1 and three parts. All subjects were supposed to receive 24 weeks (6 months) of eltrombopag treatment during Part 2/3. Screening period: Up to 28 days prior to Day 1 of treatment. Day 1 Part 1 (Dose Finding Phase): A 24-week (6 months) open label treatment period for 5 subjects in each age cohort. (short: P1W1-P1W7, P1W8-23, P1W24/EW). A safety, PK and platelet count review took place after 12 weeks (3 months) of treatment. Subjects in the Dose Finding Phase did not participate in the Randomized Period. Part 2 (Randomized Period): A 7-week randomized, double-blind, placebo-controlled period involving 18 subjects per cohort (short: P2W1-P2W7). Part 3: An open-label treatment period where subjects randomized to eltrombopag in Part 2 received an additional 17 weeks of eltrombopag in Part 3 and subjects randomized to placebo in Part 2 received 24 weeks of eltrombopag in Part 3 (short: P3W8-P3W23, P3W24/EW, P3W8-30, P3W31/EW). Follow-up: 4 weeks following the last dose of eltrombopag (short: FUW1- FUW4). Additional ocular examinations were performed at 12 and 24 weeks (3 and 6 months) after the last dose of eltrombopag (short: FUM3, FUM6). The subjects were enrolled in 3 cohorts: Cohort 1: Subjects between 12 and 17 years old (<18 years of age at Day 1). Cohort 2: Subjects between 6 and 11 years old (<12 years of age at Day 1). Cohort 3: Subjects between 1 and 5 years old (<6 years of age at Day 1). The enrollment was started with the oldest cohort (Cohort 1). The younger cohorts were not enrolled until safety, PK and platelet counts had been reviewed in the older cohort(s). This document contains the Liver Labs (Lab tests exclusive to liver events) and the viral tests for liver events form. It has to be filled in as repeating form.
Link
https://clinicaltrials.gov/ct2/show/NCT00908037
Palabras clave
Versiones (2)
- 24/10/19 24/10/19 -
- 5/12/19 5/12/19 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
5 de diciembre de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Effects of eltrombopag in children with chronic idiopathic thrombocytopenic purpura NCT00908037
Liver Lab tests and viral tests for liver events
- StudyEvent: ODM
Descripción
Lab name and address
Alias
- UMLS CUI-1
- C0022877
- UMLS CUI-2
- C1442065
- UMLS CUI-3
- C0027365
Descripción
Test set type
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0332307
Descripción
Laboratory ID
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2986056
Descripción
If you tick "Different from Screening Lab", please provide the Name and adress of laboratory in the following items.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0022877
Descripción
Laboratory name
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3258037
Descripción
Laboratory Address
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1442065
- UMLS CUI [1,2]
- C0022877
Descripción
Lab tests exclusive to liver events (Liver Lab)
Alias
- UMLS CUI-1
- C0023884
- UMLS CUI-2
- C0877248
- UMLS CUI-3
- C0022885
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1302413
Descripción
00:00-23:59
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0200345
Descripción
Fill in this itemgroup for each procedure.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0022885
Descripción
Fill in the respective item if character or numeric result.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C1274040
Descripción
Numeric result
Tipo de datos
float
Alias
- UMLS CUI [1]
- C2347373
Descripción
Character result
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2350015
- UMLS CUI [1,2]
- C1274040
Descripción
Viral tests for liver events
Alias
- UMLS CUI-1
- C1273421
- UMLS CUI-2
- C0023884
- UMLS CUI-3
- C0877248
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1302413
Descripción
Fill in this itemgroup for each viral test.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1273421
Descripción
Fill in the respective item if character or numeric result.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1273421
- UMLS CUI [1,2]
- C1274040
Descripción
Numeric result
Tipo de datos
float
Alias
- UMLS CUI [1]
- C2347373
Descripción
Character result
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2350015
- UMLS CUI [1,2]
- C1274040
Descripción
Assay Version
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2985700
Similar models
Liver Lab tests and viral tests for liver events
- StudyEvent: ODM
C1442065 (UMLS CUI-2)
C0027365 (UMLS CUI-3)
C0022877 (UMLS CUI [1,2])
C0877248 (UMLS CUI-2)
C0022885 (UMLS CUI-3)
C0200345 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C0023884 (UMLS CUI-2)
C0877248 (UMLS CUI-3)
C1274040 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])